Source: Health Products and Food Branch (CA) Revision Year: 2018
NUBAIN – Nalbuphine Hydrochloride Injection, 10 mg/mL.
| Route of Administration | Dosage Form/Strength | Clinically Relevant Nonmedicinal Ingredients |
|---|---|---|
| Subcutaneously, intramuscularly or intravenously | Solution for injection | Sodium chloride, sodium citrate dihydrate, citric acid and water for injection. For a complete listing see Dosage Forms, Composition and Packaging section. |
NUBAIN (10.0 mg/mL) 1 mL Ampoule: Each mL contains 10.0 mg nalbuphine hydrochloride, 2.0 mg sodium chloride, 9.41 mg sodium citrate dihydrate, 12.62 mg citric acid and water for injection; pH adjusted with hydrochloric acid.
NUBAIN is available in 1 mL ampoules, boxes of 2 × 5 ampoules.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Sandoz Canada Inc., 145 Jules-Léger, Boucherville, Quebec, J4B 7K8 213120 |
Date of revision:
April 3, 2018 |
| Drug | Countries | |
|---|---|---|
| NUBAIN | Austria, Brazil, Canada |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
